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Background: Methods for objective evaluation of stress in animals are important, but clinically difficult. An
alternative method to study the sympathetic activity may be to investigate Chromogranin A (CGA), Chromogranin B
(CGB) and Secretogranin II (SG2). The aim of this study was to investigate the cross-reactivity of CGA, CGB and SG2
between man, cat and dog and to explore possibilities to measure these proteins in samples from cats and dogs.
Results: Adrenal gland extracts from feline and canine species were measured by region-specific radioimmunoassays
in different dilution steps to explore possible inter species cross reactivity. High cross reactivity was found for cats in the
CGA17-38, CGA324-337, CGA361-372, CGB and SG2 assays. High cross reactivity was found for dogs in the CGA17-38,
CGA361-372, CGB and SN assays. The method measuring the intact CGA was not useful for measurements in cats
and dogs.
Conclusions: Region-specific assays measuring defined parts of CGA, CGB and SG2 can be used for measurements in
samples from cats and dogs. These results are promising and will allow for further studies of these proteins as possible
clinical biomarkers in cats and dogs.
Keywords: Chromogranin, Secretogranin, Canine, Feline, Human, RadioimmunoassayBackground
Methods for objective evaluation of stress in animals are
important, but clinically difficult. An alternative method
to study the sympathetic activity may be to investigate
Chromogranin A (CGA). CGA is part of a family of acidic
and water soluble proteins called Granins, which also in-
clude Chromogranin B (CGB) and Secretogranins (SG) II-
VII [1]. The Granins are stored in secretory granules of
neuroendocrine tissues (chromaffin cells) and are released
together with noradrenalin and adrenalin. Especially CGA
is considered a reliable indicator of activation of the sym-
pathetic tone [1,2]. Clinically, CGA and CGB are used for
diagnosis and follow-up of various endocrine tumours [1].
CGA has also been proposed for evaluation of stress in in-
tensive care units and for assessment of cardiovascular
risk [3]. In critically ill patients an increased concentration
of CGA is associated with shorter survival [4-8]. There are
considerable differences in the amino acid composition
between different animals and commercial assays for* Correspondence: Mats.Stridsberg@medsci.uu.se
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uring CGA in samples from other species. However, some
specific parts of the molecule have a higher degree of
amino acid homology and methods where the antibodies
are directed against specific epitopes can be used to meas-
ure samples from different animals [9].
The aim of this study was to investigate the cross-
reactivity of CGA, CGB and SG2 between man, cat and
dog and to explore possibilities to measure these proteins
in samples from cats and dogs.Methods
Collection of adrenals and extraction of Chromogranins
Adrenals were removed from a feline (Domestic short
hair) and canine (German shepherd) specimen euthanized
for reasons not associated with this study. The adrenals
were weighed, frozen and lyophilized. The lyophilized ma-
terial was homogenized in distilled water and boiled for
5 min. The mixture was centrifuged at 10 000 g for
15 min and the resulting supernatant was frozen in ali-
quots until measurements.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Aliquots of supernatant derived from extracted adrenals
were serial diluted in assay buffer and measured in the
respective Granin assays. All assays were competitive radio-
immunoassays, measuring defined parts of the Granin mol-
ecules. In this setting 5 region-specific assays were tested
for determination of feline and canine CGA (CGA17-38,
CGA176-195, CGA238-247, CGA324-337 and CGA361-
372) [10]. The extracts were also tested in an assay measur-
ing Secretoneurin (SN), which is a defined part of SG2 [11],
and in two commercial radioimmunoassays measuring hu-
man CGA and CGB (Eurodiagnostica AB, Malmö Sweden).
All assays had a total assay variation of <9%.
Amino acid sequences for Chromogranins
Amino acid sequences for CGA (Accession numbers
AAB53685. XP_006933167, XP_005623224), CGB (Acces-
sion numbers NP_001810, XP_006930003, XP_005634865)
and SG2 (Accession numbers AAA36607, ABD24220,
XP_545669) for human, feline and canine respectively, were
obtained from the NCBI Protein data base.
Statistics
Measured values were expressed as mean values, standard
deviation and coefficient of variation (CV)% (=%SD/MV).
Results
The results from the measurements of CGA, CGB and
SN in the adrenal extracts from cats are shown in
Table 1 and the results from the measurements in dogs
are shown in Table 2. Different concentrations were ob-
tained with the different region-specific assays for CGA
and the other assays. Low CV indicates reproducible
measurements in different dilutions, which is a reliable in-
dicator of high cross-reactivity. High CV, on the other
hand, indicates deviating results as signs of low cross-
reactivity and these concentration results cannot be consid-
ered as true estimates. Since the total assay variation in all
assays were <9%, a CV of <13.5% (=1.5xCV) was used asTable 1 Assays used for the cross reactivity studies in adrena
Assay MV SD
CGA 17-38 3,26 0,16
CGA 176-195 0,14 0,02
CGA 238-247 0,23 0,08
CGA 324-337 3,04 0,88
CGA 361-372 1,16 0,04
SG2 154-165 3,79 0,10
CGB (Eurodiagnostica) 2,31 0,30
CGA (Eurodiagnostica) 14,63 3,23
The table shows the assays used for the cross reactivity studies of Chromogranin A
adrenal extracts from cat. A coefficient of variation (CV = SD/MV) less than 13.5% (=
as a suitable assay, see text for explanation. The amino acid (Aa) homology betweethe criterion to accept an assay as suitable for measure-
ments in the feline or canine species. Low CV was found
for cats in the CGA17-38, the CGA324-337, CGA361-372,
the CGB and the SN assays. Low CV was found for dogs in
the CGA17-38, the CGA361-372, the CGB and the SN as-
says. The method measuring the whole intact CGA was not
useful for measurements in cats and dogs.
The amino acid sequence homology between human
and feline was highest for CGA17-38 (100%). Likewise, the
homology was high, 100%, for SN, whereas the other as-
says had about 50-90% amino acid homology (Table 1).
The amino acid sequence homology between human and
canine was highest for CGA17-38 (100%) and the hom-
ology was high, 100%, also for SN, whereas the other as-
says had about 70-80% amino acid homology (Table 2).
Discussion
The aim of this study was to investigate the cross-
reactivity of CGA between man, cat and dog and to ex-
plore possibilities to measure CGA in samples from cats
and dogs. Since plasma samples with high concentrations
of CGA are difficult to find in animals, we choose to use
extracts of Chromogranins from adrenal glands, an organ
known to contain high concentrations of CGA, CGB and
SG2 [12]. Using the supernatant from adrenal extracts, we
were able to obtain high enough concentrations to allow
serial dilution, which is an established way to explore cross
reactivity. Similar experiments have been performed earl-
ier for bovine, equine, ovine and caprine species [9]. In
agreement with our results, as in the previous study [9],
the CGA17-38 assay showed cross reactivity between the
species, while the CGA assay measuring the whole intact
CGA molecule, which corresponds to the Eurodiagnostica
assay used in this study, was not useful. Interestingly,
some assays with lower amino acid homology showed
cross reactivity, while others did not. It is known that, in
particular, charged amino acids are highly immunoreac-
tive. An exchange between species of one or more of these
crucial amino acids will give a high impact on the antibodyl extracts from cat
CV Suitable assay Aa homology
4,8% Yes 100%
16,7% No 59%
35,4% No 90%
29,0% No 93%
3,4% Yes 83%
2,7% Yes 100%
12,8% Yes 85%
22,1% No
(CGA), Chromogranin B (CGB) and Secretogranin II (SG2) measurements in
1.5 x assay CV) was considered acceptable for measurements i.e. determined
n the human and feline species is indicated for the different assays.
Table 2 Assays used for the cross reactivity studies in adrenal extracts from dog
Assay MV SD CV Suitable assay Aa homology
CGA 17-38 3,02 0,26 8,8% Yes 100%
CGA 176-195 0,10 0,02 15,5% No 79%
CGA 238-247 0,24 0,11 47,0% No 75%
CGA 324-337 1,41 0,18 12,7% Yes 79%
CGA 361-372 0,46 0,02 3,6% Yes 70%
SG2 154-165 7,22 0,48 6,7% Yes 100%
CGB (Eurodiagnostica) 3,89 0,42 10,7% Yes 77%
CGA (Eurodiagnostica) 4,99 1,22 24,5% No
The table shows the assays used for the cross reactivity studies of Chromogranin A (CGA), Chromogranin B (CGB) and Secretogranin II (SG2) measurements in
adrenal extracts from dog. A coefficient of variation (CV = SD/MV) less than 13.5% (=1.5 x assay CV) was considered acceptable for measurements i.e. determined
as a suitable assay, see text for explanation. The amino acid (Aa) homology between the human and canine species is indicated for the different assays.
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tution has occurred for the CGA176-195 and CGA238-
247 parts of the molecule in cats and for the CGA176-1
95, CGA238-247 and CGA324-337 epitopes in dogs, thus
explaining the poor cross reactivity although the apparent
amino acid homology was rather high. Some CGA assays
in the present study appear to be useful for measurements
of Chromogranins in both cats and dogs. These assays
measure known epitopes of CGA, which have been identi-
fied with biological activity (the CGA17-38 is also called
Vasostatin and the CGA361-372 is also called Catestatin
[13]). This is also the case with the part of SG2, i.e. SN, we
have used in this study [11]. It is thus likely that peptides
with biological activity have highly conserved inter-species
amino acid homology and, as seen in this study, are useful
for quantitative measurements.
All assays used in this study have previously been used
for measurements of circulating concentrations of Chro-
mogranins in plasma from human patients with neuroen-
docrine tumours [11,13]. However, Chromogranins have
multiple sites that are likely to be cleaved both before and
after release to the circulation. Accordingly different mo-
lecular forms of Chromogranins are likely to be found in
the circulation. A more precise way to estimate the circu-
lating concentrations of Chromogranins and other pro-
teins, processing-independent assays, has been presented
[14]. However, the use of region-specific assays with de-
fined antibody epitopes, as in this study, can also be a way
to assess the problem with different circulating molecular
forms. It has also been shown that circulating concentra-
tions of Chromogranins has a diurnal variation, a fact that
should be considered in the planning of experiments [15].
CGA has been measured in plasma from cats and dogs
with antibodies directed against both the C-terminal and
the N-terminal of human CGA [16]. CGA has also been
measured in plasma samples and adrenal extract from dogs
[17,18]. Salivary concentrations have been measured in
dogs [19]. This was done with an ELISA-kit from Yanaihara
Institute, Japan, where the antibodies were directed againstthe epitope CGA344-374, which roughly covers the same
region as one of the assays in this study, CGA361-372
(Catestatin).
Conclusions
In conclusion, we have identified parts of CGA, CGB
and SG2 and assays that can be used for measurements
of samples from cats and dogs. These results are promis-
ing and will allow for further studies of these proteins as
possible clinical biomarkers for sympathetic activity and
stressful situations in cats and dogs and possible even
other diseases.
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